A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.
scientific article published on 2 February 2018
Author/s
author: Susana Kalko, Alfons Navarro, Montserrat Torrebadell, Marina Díaz-Beyá, Marta Pratcorona, Josep Nomdedeu, Bernat Gel, Salut Brunet, Jorge Sierra, Mireia Camós, Jordi Esteve
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.